<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32399947</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>Myristoylation of EV71 VP4 is Essential for Infectivity and Interaction with Membrane Structure.</ArticleTitle><Pagination><StartPage>599</StartPage><EndPage>613</EndPage><MedlinePgn>599-613</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12250-020-00226-1</ELocationID><Abstract><AbstractText>The Enterovirus 71 (EV71) VP4 is co-translationally linked to myristic acid at its amino-terminal glycine residue. However, the role of this myristoylation in the EV71 life cycle remains largely unknown. To investigate this issue, we developed a myristoylation-deficient virus and reporter (luciferase) pseudovirus with a Gly-to-Ala mutation (G2A) on EV71 VP4. When transfecting the EV71-G2A genome encoding plasmid in cells, the loss of myristoylation on VP4 did not affect the expression of viral proteins and the virus morphology, however, it did significantly influence viral infectivity. Further, in myristoylation-deficient reporter pseudovirus-infected cells, the luciferase activity and viral genome RNA decreased significantly as compared to that of wild type virus; however, cytopathic effect and viral capsid proteins were not detected in myristoylation-deficient virus-infected cells. Also, although myristoylation-deficient viral RNA and proteins were detected in the second blind passage of infection, they were much fewer in number compared to that of the wild type virus. The replication of genomic RNA and negative-strand viral RNA were both blocked in myristoylation-deficient viruses, suggesting that myristoylation affects viral genome RNA release from capsid to cytoplasm. Besides, loss of myristoylation on VP4 altered the distribution of VP4-green fluorescent protein protein, which disappeared from the membrane structure fraction. Finally, a liposome leakage assay showed that EV71 myristoylation mediates the permeability of the model membrane. Hence, the amino-terminal myristoylation of VP4 is pivotal to EV71 infection and capsid-membrane structure interaction. This study provides novel molecular mechanisms regarding EV71 infection and potential molecular targets for antiviral drug design.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Jiaming</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hongtao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun, 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun, 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun, 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Linjun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun, 130012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Weiheng</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-9577-7423</Identifier><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China. suweiheng@jlu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun, 130012, China. suweiheng@jlu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Chunlai</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4497-5315</Identifier><AffiliationInfo><Affiliation>National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, 130012, China. jiangcl@jlu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun, 130012, China. jiangcl@jlu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0I3V7S25AW</RegistryNumber><NameOfSubstance UI="D019814">Myristic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002213" MajorTopicYN="N">Capsid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019814" MajorTopicYN="N">Myristic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus 71 (EV71)</Keyword><Keyword MajorTopicYN="N">Infectivity</Keyword><Keyword MajorTopicYN="N">Membrane structure</Keyword><Keyword MajorTopicYN="N">Myristoylation</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32399947</ArticleId><ArticleId IdType="pmc">PMC7736455</ArticleId><ArticleId IdType="doi">10.1007/s12250-020-00226-1</ArticleId><ArticleId IdType="pii">10.1007/s12250-020-00226-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alexander JP, Jr, Baden L, Pallansch MA, Anderson LJ. Enterovirus 71 infections and neurologic disease&#x2014;United States, 1977&#x2013;1991. J Infect Dis. 1994;169:905&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">8133108</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansardi DC, Porter DC, Morrow CD. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles. J Virol. 1992;66:4556&#x2013;4563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC241268</ArticleId><ArticleId IdType="pubmed">1318418</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Nagata N, Sata T, Miyamura T, Shimizu H. Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon. J Gen Virol. 2006;87:3317&#x2013;3327.</Citation><ArticleIdList><ArticleId IdType="pubmed">17030866</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutin JA. Myristoylation. Cell Signal. 1997;9:15&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">9067626</ArticleId></ArticleIdList></Reference><Reference><Citation>Braam B, Verhaar MC. Understanding eNOS for pharmacological modulation of endothelial function: a translational view. Curr Pharm Des. 2007;13:1727&#x2013;1740.</Citation><ArticleIdList><ArticleId IdType="pubmed">17584103</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryant M, Ratner L. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc Natl Acad Sci USA. 1990;87:523&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC53297</ArticleId><ArticleId IdType="pubmed">2405382</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J, Liu H, Qu M, Hou A, Zhou Y, Sun B, Cai L, Gao F, Su W, Jiang C. Determination of the cleavage site of enterovirus 71 VP0 and the effect of this cleavage on viral infectivity and assembly. Microb Pathog. 2019;134:103568.</Citation><ArticleIdList><ArticleId IdType="pubmed">31195113</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman MS, Rossmann MG. Comparison of surface properties of picornaviruses: strategies for hiding the receptor site from immune surveillance. Virology. 1993;195:745&#x2013;756.</Citation><ArticleIdList><ArticleId IdType="pubmed">8337843</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow M, Moscufo N. Myristoyl modification of viral proteins: assays to assess functional roles. Methods Enzymol. 1995;250:495&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">7651174</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow M, Newman JF, Filman D, Hogle JM, Rowlands DJ, Brown F. Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature. 1987;327:482&#x2013;486.</Citation><ArticleIdList><ArticleId IdType="pubmed">3035380</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov M, Voroshilova M, Shindarov L, Lavrova I, Gracheva L, Koroleva G, Vasilenko S, Brodvarova I, Nikolova M, Gyurova S, Gacheva M, et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol. 1979;60:329&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">228639</ArticleId></ArticleIdList></Reference><Reference><Citation>Colomer-Lluch M, Serra-Moreno R. BCA2/Rabring7 Interferes with HIV-1 proviral transcription by enhancing the SUMOylation of I&#x3ba;B&#x3b1;. J Virol. 2017;91:e02098-16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5375697</ArticleId><ArticleId IdType="pubmed">28122985</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbic Ramljak I, Stanger J, Real-Hohn A, Dreier D, Wimmer L, Redlberger-Fritz M, Fischl W, Klingel K, Mihovilovic MD, Blaas D, Kowalski H. Cellular N-myristoyltransferases play a crucial picornavirus genus-specific role in viral assembly, virion maturation, and infectivity. PLoS Pathog. 2018;14:e1007203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6089459</ArticleId><ArticleId IdType="pubmed">30080883</ArticleId></ArticleIdList></Reference><Reference><Citation>Courtneidge SA, Bishop JM. Transit of pp60v-src to the plasma membrane. Proc Natl Acad Sci USA. 1982;79:7117&#x2013;7121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC347289</ArticleId><ArticleId IdType="pubmed">6296817</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis MP, Bottley G, Beales LP, Killington RA, Rowlands DJ, Tuthill TJ. Recombinant VP4 of human rhinovirus induces permeability in model membranes. J Virol. 2008;82:4169&#x2013;4174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2293005</ArticleId><ArticleId IdType="pubmed">18256154</ArticleId></ArticleIdList></Reference><Reference><Citation>Eash S, Querbes W, Atwood WJ. Infection of vero cells by BK virus is dependent on caveolae. J Virol. 2004;78:11583&#x2013;11590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC523296</ArticleId><ArticleId IdType="pubmed">15479799</ArticleId></ArticleIdList></Reference><Reference><Citation>Farazi TA, Waksman G, Gordon JI. The biology and enzymology of protein N-myristoylation. J Biol Chem. 2001;276:39501&#x2013;39504.</Citation><ArticleIdList><ArticleId IdType="pubmed">11527981</ArticleId></ArticleIdList></Reference><Reference><Citation>Filman DJ, Syed R, Chow M, Macadam AJ, Minor PD, Hogle JM. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 1989;8:1567&#x2013;1579.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC400988</ArticleId><ArticleId IdType="pubmed">2548847</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs R, Blaas D. Uncoating of human rhinoviruses. Rev Med Virol. 2010;20:281&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pubmed">20629045</ArticleId></ArticleIdList></Reference><Reference><Citation>Geyer M, Peterlin BM. Domain assembly, surface accessibility and sequence conservation in full length HIV-1 Nef. FEBS Lett. 2001;496:91&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">11356189</ArticleId></ArticleIdList></Reference><Reference><Citation>Giese SI, Woerz I, Homann S, Tibroni N, Geyer M, Fackler OT. Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef Virol. 2006;355:175&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">16916529</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodwin S, Tuthill TJ, Arias A, Killington RA, Rowlands DJ. Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner. J Virol. 2009;83:11275&#x2013;11282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2772760</ArticleId><ArticleId IdType="pubmed">19710148</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon JI, Duronio RJ, Rudnick DA, Adams SP, Gokel GW. Protein N-myristoylation. J Biol Chem. 1991;266:8647&#x2013;8650.</Citation><ArticleIdList><ArticleId IdType="pubmed">2026581</ArticleId></ArticleIdList></Reference><Reference><Citation>Heuckeroth RO, Gordon JI. Altered membrane association of p60v-src and a murine 63-kDa&#xa0;N-myristoyl protein after incorporation of an oxygen-substituted analog of myristic acid. Proc Natl Acad Sci USA. 1989;86:5262&#x2013;5266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC297601</ArticleId><ArticleId IdType="pubmed">2501783</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill BT, Skowronski J. Human N-myristoyltransferases form stable complexes with lentiviral nef and other viral and cellular substrate proteins. J Virol. 2005;79:1133&#x2013;1141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC538564</ArticleId><ArticleId IdType="pubmed">15613341</ArticleId></ArticleIdList></Reference><Reference><Citation>Horodniceanu F, Panon G, Le Fur R, Barme M. Purification of poliovirus obtained from human diploid cells by means of DEAE-Sepharose. Dev Biol Stand. 1979;42:75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">223925</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P, Liu Y, Ma HC, Paul AV, Wimmer E. Picornavirus morphogenesis. Microbiol Mol Biol Rev. 2014;78:418&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4187686</ArticleId><ArticleId IdType="pubmed">25184560</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J, Xu L, Guo SJ, Sun SY, Zhang S, Zhu CL, Kong W, Jiang CL. Safe and objective assay of enterovirus 71 neutralizing antibodies via pseudovirus. Chem Res Chin U. 2012;28:91&#x2013;95.</Citation></Reference><Reference><Citation>Jin J, Ma H, Xu L, An D, Sun S, Huang X, Kong W, Jiang C. Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum. J Virol Methods. 2013;187:362&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112850</ArticleId><ArticleId IdType="pubmed">23178532</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson DR, Cox AD, Solski PA, Devadas B, Adams SP, Leimgruber RM, Heuckeroth RO, Buss JE, Gordon JI. Functional analysis of protein N-myristoylation: metabolic labeling studies using three oxygen-substituted analogs of myristic acid and cultured mammalian cells provide evidence for protein-sequence-specific incorporation and analog-specific redistribution. Proc Natl Acad Sci USA. 1990;87:8511&#x2013;8515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC54986</ArticleId><ArticleId IdType="pubmed">2236060</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson DR, Bhatnagar RS, Knoll LJ, Gordon JI. Genetic and biochemical studies of protein N-myristoylation. Annu Rev Biochem. 1994;63:869&#x2013;914.</Citation><ArticleIdList><ArticleId IdType="pubmed">7979256</ArticleId></ArticleIdList></Reference><Reference><Citation>Krausslich HG, Holscher C, Reuer Q, Harber J, Wimmer E. Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity. J Virol. 1990;64:2433&#x2013;2436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC249411</ArticleId><ArticleId IdType="pubmed">2157900</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YM, Chow M. Myristate modification does not function as a membrane association signal during poliovirus capsid assembly. Virology. 1992;187:814&#x2013;820. doi: 10.1016/0042-6822(92)90485-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(92)90485-8</ArticleId><ArticleId IdType="pubmed">1312279</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Fan P, Jin J, Su W, An D, Xu L, Sun S, Zhang Y, Meng X, Gao F, Kong W, Jiang C. Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2. Virol J. 2013;10:250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3765843</ArticleId><ArticleId IdType="pubmed">23919614</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Lin HY, Tsou YL, Chitra E, Hsiao KN, Shao HY, Liu CC, Sia C, Chong P, Chow YH. Human SCARB2-mediated entry and endocytosis of EV71. PLoS ONE. 2012;7:e30507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3260287</ArticleId><ArticleId IdType="pubmed">22272359</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum LC, Wong KT, Lam SK, Chua KB, Goh AY. Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis. Lancet. 1998;352:1391.</Citation><ArticleIdList><ArticleId IdType="pubmed">9802304</ArticleId></ArticleIdList></Reference><Reference><Citation>Marc D, Drugeon G, Haenni AL, Girard M, van der Werf S. Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence. EMBO J. 1989;8:2661&#x2013;2668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC401272</ArticleId><ArticleId IdType="pubmed">2555183</ArticleId></ArticleIdList></Reference><Reference><Citation>Marc D, Masson G, Girard M, van der Werf S. Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles. J Virol. 1990;64:4099&#x2013;4107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC247872</ArticleId><ArticleId IdType="pubmed">2166807</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariani R, Skowronski J. CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proc Natl Acad Sci USA. 1993;90:5549&#x2013;5553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC46758</ArticleId><ArticleId IdType="pubmed">8516299</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Belmonte F, Lopez-Guerrero JA, Carrasco L, Alonso MA. The amino-terminal nine amino acid sequence of poliovirus capsid VP4 protein is sufficient to confer N-myristoylation and targeting to detergent-insoluble membranes. Biochemistry. 2000;39:1083&#x2013;1090.</Citation><ArticleIdList><ArticleId IdType="pubmed">10653654</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez A, Traverso JA, Valot B, Ferro M, Espagne C, Ephritikhine G, Zivy M, Giglione C, Tl Meinnel. Extent of N-terminal modifications in cytosolic proteins from eukaryotes. Proteomics. 2008;8:2809&#x2013;2831.</Citation><ArticleIdList><ArticleId IdType="pubmed">18655050</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer-Stroh S, Eisenhaber B, Eisenhaber F. N-terminal N-myristoylation of proteins: prediction of substrate proteins from amino acid sequence. J Mol Biol. 2002;317:541&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">11955008</ArticleId></ArticleIdList></Reference><Reference><Citation>Moscufo N, Simons J, Chow M. Myristoylation is important at multiple stages in poliovirus assembly. J Virol. 1991;65:2372&#x2013;2380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC240589</ArticleId><ArticleId IdType="pubmed">1850017</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousnier A, Bell AS, Swieboda DP, Morales-Sanfrutos J, Perez-Dorado I, Brannigan JA, Newman J, Ritzefeld M, Hutton JA, Guedan A, Asfor AS, Robinson SW, Hopkins-Navratilova I, Wilkinson AJ, Johnston SL, Leatherbarrow RJ, Tuthill TJ, Solari R, Tate EW. Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus. Nat Chem. 2018;10:599&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015761</ArticleId><ArticleId IdType="pubmed">29760414</ArticleId></ArticleIdList></Reference><Reference><Citation>Olokoltsov AA, Deniger D, Fleming EH, Roberts NJ, Jr, Karpilow JM, Davey RA. Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. J Virol. 2007;81:7786&#x2013;7800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1933373</ArticleId><ArticleId IdType="pubmed">17494077</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul AV, Schultz A, Pincus SE, Oroszlan S, Wimmer E. Capsid protein VP4 of poliovirus is N-myristoylated. Proc Natl Acad Sci USA. 1987;84:7827&#x2013;7831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC299409</ArticleId><ArticleId IdType="pubmed">2825164</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul AV, Rieder E, Kim DW, van Boom JH, Wimmer E. Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J Virol. 2000;74:10359&#x2013;10370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110910</ArticleId><ArticleId IdType="pubmed">11044080</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng B, Robert-Guroff M. Deletion of N-terminal myristoylation site of HIV Nef abrogates both MHC-1 and CD4 down-regulation. Immunol Lett. 2001;78:195&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">11578695</ArticleId></ArticleIdList></Reference><Reference><Citation>Raju RV, Magnuson BA, Sharma RK. Mammalian myristoyl CoA: protein N-myristoyltransferase. Mol Cell Biochem. 1995;149&#x2013;150:191&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">8569729</ArticleId></ArticleIdList></Reference><Reference><Citation>Rein A, McClure MR, Rice NR, Luftig RB, Schultz AM. Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc Natl Acad Sci USA. 1986;83:7246&#x2013;7250. doi: 10.1073/pnas.83.19.7246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.83.19.7246</ArticleId><ArticleId IdType="pmc">PMC386692</ArticleId><ArticleId IdType="pubmed">3489936</ArticleId></ArticleIdList></Reference><Reference><Citation>Resh MD. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim Biophys Acta. 1999;1451:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">10446384</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee SS, Hunter E. Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids. J Virol. 1987;61:1045&#x2013;1053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC254061</ArticleId><ArticleId IdType="pubmed">3493352</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss M, Levy HC, Bostina M, Filman DJ, Hogle JM. RNA transfer from poliovirus 135S particles across membranes is mediated by long umbilical connectors. J Virol. 2013;87:3903&#x2013;3914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3624230</ArticleId><ArticleId IdType="pubmed">23365424</ArticleId></ArticleIdList></Reference><Reference><Citation>Strecker T, Maisa A, Daffis S, Eichler R, Lenz O, Garten W. The role of myristoylation in the membrane association of the Lassa virus matrix protein Z. Virol J. 2006;3:93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1647273</ArticleId><ArticleId IdType="pubmed">17083745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan YW, Hong WJ, Chu JJ. Inhibition of enterovirus VP4 myristoylation is a potential antiviral strategy for hand, foot and mouth disease. Antiviral Res. 2016;133:191&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">27520386</ArticleId></ArticleIdList></Reference><Reference><Citation>Thinon E, Serwa RA, Broncel M, Brannigan JA, Brassat U, Wright MH, Heal WP, Wilkinson AJ, Mann DJ, Tate EW. Global profiling of co- and post-translationally N-myristoylated proteomes in human cells. Nat Commun. 2014;5:4919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4200515</ArticleId><ArticleId IdType="pubmed">25255805</ArticleId></ArticleIdList></Reference><Reference><Citation>Udenwobele DI, Su RC, Good SV, Ball TB, Varma Shrivastav S, Shrivastav A. Myristoylation: an important protein modification in the immune response. Front Immunol. 2017;8:751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5492501</ArticleId><ArticleId IdType="pubmed">28713376</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner E, Plank C, Zatloukal K, Cotten M, Birnstiel ML. Influenza virus hemagglutinin HA-2&#xa0;N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA. 1992;89:7934&#x2013;7938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC49829</ArticleId><ArticleId IdType="pubmed">1518816</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver TA, Panganiban AT. N myristoylation of the spleen necrosis virus matrix protein is required for correct association of the Gag polyprotein with intracellular membranes and for particle formation. J Virol. 1990;64:3995&#x2013;4001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC249699</ArticleId><ArticleId IdType="pubmed">2164607</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox C, Hu JS, Olson EN. Acylation of proteins with myristic acid occurs cotranslationally. Science. 1987;238:1275&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pubmed">3685978</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills JW, Craven RC, Achacoso JA. Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells. J Virol. 1989;63:4331&#x2013;4343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC251050</ArticleId><ArticleId IdType="pubmed">2550669</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright MH, Heal WP, Mann DJ, Tate EW. Protein myristoylation in health and disease. J Chem Biol. 2010;3:19&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2816741</ArticleId><ArticleId IdType="pubmed">19898886</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Su W, Jin J, Chen J, Li X, Zhang X, Sun M, Sun S, Fan P, An D, Zhang H, Zhang X, Kong W, Ma T, Jiang C. Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening. Viruses. 2014;6:2778&#x2013;2795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4113793</ArticleId><ArticleId IdType="pubmed">25036464</ArticleId></ArticleIdList></Reference><Reference><Citation>Zauner W, Blaas D, Kuechler E, Wagner E. Rhinovirus-mediated endosomal release of transfection complexes. J Virol. 1995;69:1085&#x2013;1092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC188680</ArticleId><ArticleId IdType="pubmed">7815487</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Dong M, Jiang B, Dai X, Meng J. Antigenic characteristics of the complete and truncated capsid protein VP1 of enterovirus 71. Virus Res. 2012;167:337&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pubmed">22659489</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YX, Huang YM, Li QJ, Li XY, Zhou YD, Guo F, Zhou JM, Cen S. A highly conserved amino acid in VP1 regulates maturation of enterovirus 71. PLoS Pathog. 2017;13:e1006625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5634653</ArticleId><ArticleId IdType="pubmed">28938017</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Luo S, Sabo Y, Wang C, Tong L, Goff SP. Heme oxygenase 2 binds myristate to regulate retrovirus assembly and TLR4 signaling. Cell Host Microbe. 2017;21:220&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5300893</ArticleId><ArticleId IdType="pubmed">28132836</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>